NEXTHERA CAPITAL LP current holdings: Foreign ADRs
NEXTHERA CAPITAL LP reported $0.03 billion in depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), 3 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are GlaxoSmithKline PLC, Shire PLC, Ascendis Pharma A/S.
- GlaxoSmithKline PLC: Country of operation —; Class SPONSORED ADR; Shares 345,000; Value $14,880,000.
- Shire PLC: Country of operation —; Class SPONSORED ADR; Shares 67,000; Value $12,989,000.
- Ascendis Pharma A/S: Country of operation —; Class SPONSORED ADR; Shares 146,200; Value $2,939,000.
Form 13F-HR as filed (SEC CIK 1646343): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||